维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Horban"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure显示文摘	Stanislas Pol Jeroen Aerssens Stefan Zeuzem Pietro Andreone Eric J. Lawitz Stuart Roberts Zobair Younossi Graham R. Foster Roberto Focaccia Andrzej Horban Paul J. Pockros Rolf P.G. Van Heeswijk Sandra De Meyer Don Luo Martyn Botfield Maria Beumont Gaston	2013	Journal of Hepatology2013，，5：	2
2	Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients with Lamivudine-resistant Chronic Hepatitis B显示文摘	Scott Fung Peter Kwan Milotka Fabri Andrzej Horban Mijomir Pelemis Hie-Won Hann Selim Gurel Florin A. Caruntu John F. Flaherty Benedetta Massetto Phillip Dinh Amoreena Corsa G. Mani Subramanian John G. McHutchison Petr Husa Edward Gane	2013	Gastroenterology2013，，：	1
3	High prevalence of genotypic resistance to nucleoside reverse transcriptase inhibitors among therapy naive individuals from the Warsaw cohort显示文摘	Horban A Stanczak J J Bakowska E	2002	Infection2002，30，：	1
4	Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure显示文摘	Stanislas Pol Jeroen Aerssens Stefan Zeuzem Pietro Andreone Eric J. Lawitz Stuart Roberts Zobair Younossi Graham R. Foster Roberto Focaccia Andrzej Horban Paul J. Pockros Rolf P.G. Van Heeswijk Sandra De Meyer Don Luo Martyn Botfield Maria Beumont Gaston	2013	Journal of Hepatology2013，，5：	1
5	Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load显示文摘	Gordon SC Krastev Z Horban A	2013	Hepatology2013，58，2：	1
6	Telaprevir for retreatment of HCV infection 显示文摘	Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Foeaccia R Younossi Z Foster GR Horban A Ferenci P Nevens F Mullhaupt B Pockros P Terg R Shouval D van Hoek B Weiland O Van Heeswijk R De Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M REALIZE Study Team	2011	N Engl J Med2011，364，25：	1
7	Central nervous sys tern as a possible site of HCV replication 显示文摘	Bednarska A Horban A Rafkowski M	2007	Przegl Epidemiol2007，61，4：	1
8	Mecha- nism of warm and cold roll bonding of aluminum al- loy strips 显示文摘	Eizadjou M Danesh M H Jang Horban K	2009	Materials and Design2009，30，10：	1
9	Telaprevir for retreatment of HCV infection显示文摘	Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Focaccia R Younossi Z Foster G R Horban A Ferenci P Nevens F Müllhaupt B Pockros P Terg R Shouval D Hoek B Weiland O Heeswijk R Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M	2011	N Engl J Med2011，364，25：	1
10	Prevalence and risk factors of HCV infection in Poland显示文摘	Robert Flisiak Waldemar Halota Andrzej Horban Jacek Juszczyk Malgorzata Pawlowska Krzysztof Simon	2011	European Journal of Gastroenterology & Hepatology2011，，12：	1
11	The cyclophilin inhibitor DEBIO -025 has a potent dual anti -HCV activity in treatment - naive HIV/HCV co -infected subjects显示文摘	Fu&IK -R HORBAN --A ' KIEFt(US J	2006	Hepa- tology2006，44，1：	1
12	Mechanism of warm and cold roll bonding of aluminum alloy strips 显示文摘	Eizadjou M Danesh M H Jang Horban K	2009	Materials and Design2009，30，10：	1
13	Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C显示文摘	Michael Manns Stefan Zeuzem Ajit Sood Yoav Lurie Markus Cornberg Hartwig Klinker Peter Buggisch Martin R?ssle Holger Hinrichsen Ismail Merican Yaron Ilan Stefan Mauss Saif Abu-Mouch Andryes Horban Thomas H. Müller Christoph Welsch Rongdean Chen Rab Faruqi		Journal of Hepatology0，，：	1
14	The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus显示文摘	Flisiak R Horban A Gallay P		0，，：	1
15	The morphofunctional changes in the air-blood barrier in hypostatic pneumonia显示文摘	Korchyns OO Horban VO	1996	Lik Sprava1996，，56：	1
16	Correlation between function and proto-oncogene expression in isolated working rat hearts under various overload conditions 显示文摘	Horban A Kolbeck-Ruhmkorff C Zimmer HG	1997	J Mol Cell Cardiol1997，29，11：	1
17	Maraviroc for previously treated patients with R5 HIV-1 infection 显示文摘	Gulick RM Lalezari J Goodrich J Clumeck N DeJesus E Horban A Nadler J Clotet B Karlsson A Wohlfeiler M Montana JB McHale M Sullivan J Ridgway C Fel-stead S Dunne MW van der Ryst E Mayer H	2008	N Engl J Med2008，359，14：	1
18	Assessment of geographic accessibility to pharmacy in Qom, Iran : a ge- ographic information system analysis 显示文摘	Amir Hashemi Meshkini Abbas Kebriaeezadeh Mohammad Reza Jang- horban	2014	Thrita2014，，1：	1
19	Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load 显示文摘	Gordon S C Krastev Z Horban A	2013	nepatology2013，58，2：	1
20	Acute pancreatitis as a clinical presentation of COVID-19 in a patient with HIV infection:a case report显示文摘Background Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)occurs mostly as a respiratory tract infection;however,a substantial proportion of patients present with other symptoms[1].In order to enter a cell,the SARS-CoV-2 virus requires an angiotensin-converting enzyme 2(ACE2)transmembrane protein(ACE2 receptor).ACE2 receptors are>100 times more common in the gastrointestinal(GI)tract than in the respiratory tract,and many SARS-CoV-2-infected patients present with GI symptoms[2].In the course of coronavirus disease 2019(COVID-19).	Justyna D.Kowalska Carlo Bienkowski Beata Wojtycha-Kwasnica Pawel Uliczny Andrzej Horban	2022	Gastroenterology Report2022，10，1：	0

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示